Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report

BACKGROUND: Erdheim-Chester disease is a rare histiocytosis characterized by multi-systemic organ involvement. Immune-modulating agents such as interferon-alpha have limited success and the disorder is progressive and causes high morbidity and mortality. Treatment with the BRAF-inhibitor vemurafenib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Res Notes
Autors principals: Tzoulis, Charalampos, Schwarzlmüller, Thomas, Gjerde, Ivar Otto, Søfteland, Eirik, Neckelmann, Gesche, Biermann, Martin, Haroche, Julien, Straume, Oddbjørn, Vintermyr, Olav Karsten
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4450489/
https://ncbi.nlm.nih.gov/pubmed/25926131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1135-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars